Management of Neuropathic Pain in Hospitalized Patients

Hospital Medicine Clinics

Volumn 2, Issue 4, 2013, Pages e587-e602

  Wolfe, Matthew D ^a   O'Connor, Alec B ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Allodynia; Hospitalized patient; Hyperalgesia; Neuropathic pain; Painful diabetic peripheral neuropathy

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ASCORBIC ACID; BOTULINUM TOXIN; BUPIVACAINE; CAPSAICIN; DESIPRAMINE; DULOXETINE; GABAPENTIN; IMIPRAMINE; KETAMINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MEMANTINE; MORPHINE; NORTRIPTYLINE; OPIATE; OPIATE AGONIST; PLACEBO; PREGABALIN; STEROID; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ALLODYNIA; ALTERNATIVE MEDICINE; ATAXIA; BLURRED VISION; BURNING SENSATION; CHRONIC PAIN; CLINICAL FEATURE; COMORBIDITY; CONFUSION; CONSTIPATION; CONSULTATION; DELIRIUM; DIABETIC NEUROPATHY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE COURSE; DIZZINESS; DRUG ABSORPTION; DRUG BINDING; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG WITHDRAWAL; EDEMA; ELECTROMYOGRAPHY; GAIT DISORDER; HERPES ZOSTER; HOSPITALIZATION; HUMAN; HYPERESTHESIA; MENTAL HEALTH; MYOCLONUS; NAUSEA; NERVE CONDUCTION; NEUROIMAGING; NEUROPATHIC PAIN; ORTHOSTATIC HYPOTENSION; PAIN; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PATIENT CARE; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; POSTHERPETIC NEURALGIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RADICULAR PAIN; RECOMMENDED DRUG DOSE; REVIEW; RISK ASSESSMENT; SEDATION; SIDE EFFECT; SKIN MANIFESTATION; SOMATOSENSORY SYSTEM; SOMNOLENCE; TREMOR; UNSPECIFIED SIDE EFFECT; URINE RETENTION; WEIGHT GAIN; XEROSTOMIA;

EID: 84885085784     PISSN: 22115943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehmc.2013.04.007     Document Type: Review

References (58)

1. Treede R.D., Jensen T.S., Campbell J.N., et al. Redefinition of neuropathic pain and a grading system for clinical use: consensus statement on clinical and research diagnostic criteria. Neurology 2008, 70:1630-1635.
2. Novakovic S.D., Tzoumaka F., McGivern J.G., et al. Distrubution of the tetrodotoxin-resistant sodium channel PN3 in rat sensory neurons in normal and neuropathic conditions. JNeurosci 1998, 18:543-552.
3. Bridges D., Thompson S.W., Rice A.S. Mechanisms of neuropathic pain. Br J Anaesth 2001, 87:12-26.
4. Woolf C.J., Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms and management. Lancet 1999, 353:1959-1964.
5. Jensen T.S., Baron R. Translation of symptoms and signs into mechanisms of neuropathic pain. Pain 2003, 102:1-8.
6. Mendell J.R., Sahenk Z. Painful sensory neuropathy. NEngl J Med 2003, 348(13):1243-1255.
7. Baron R., Binder A., Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 2010, 9(8):807-819.
8. Haanpaa M., Attal N., Backonja M., et al. NeuPSIG guidelines on neuropathic pain assessment. Pain 2011, 152:14-27.
9. Dworkin R.H., Backonja M., Rowbotham C., et al. Advances in neuropathic pain. Arch Neurol 2003, 60:1524-1534.
10. Baron R. Mechanisms of disease: neuropathic pain - a clinical perspective. Nat Clin Pract Neurol 2006, 2:95-105.
11. O'Connor A.B. Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy. Pharmacoeconomics 2009, 27:95-112.
12. Dworkin R.H., Malone D.C., Panarites C.J., et al. Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costs. JPain 2010, 11:360-368.
13. International Federation of Health Plans. iFHP 2011 comparative price report. Available at: Accessed March 29, 2013. http://www.ifhp.com/news97.html.
14. Dworkin R.H., O'Connor A.B., Backonja M., et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007, 132:237-251.
15. Finnerup N.B., Otto M., McQuay H.J., et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005, 118:289-305.
16. Collins S.L., Moore R.A., McQuay H.J., et al. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. JPain Symptom Manage 2000, 20:449-458.
17. O'Connor A.B., Dworkin R.H. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med 2009, 122:S22-S32.
18. Hillel C.W., Gibson G., Alderman M.H. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med 2000, 108:2-8.
19. Ray W.A., Meredit S., Thapa P.B., et al. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 2004, 75:234-241.
20. Pop-Busui R., Roberts L., Pennathur S., et al. The management of diabetic neuropathy in CKD. Am J Kidney Dis 2010, 55:365-385.
21. Raskin J., Pritchett Y.L., Wang F., et al. Adouble-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005, 6:346-356.
22. Wernicke J.F., Pritchett Y.L., D'Souza D.N., et al. Arandomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006, 67:1411-1420.
23. Goldstein D.J., Lu Y., Detke M.J., et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005, 116:109-118.
24. Rowbotham M.C., Goli V., Kunz N.R., et al. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 2004, 110:697-706.
25. Backonja M., Beydoun A., Edwards K.R., et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998, 280:1831-1836.
26. Backonja M., Glanzman R.L. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther 2003, 25:81-104.
27. Wong M.O., Eldon M.A., Keane W.F., et al. Disposition of gabapentin in the anuric subjects on hemodialysis. JClin Pharmacol 1995, 35:622-626.
28. Zhang C., Glenn D.G., Bell D.W., et al. Gabapentin-induced myoclonus in end-stage renal disease. Epilepsia 2005, 46:156-158.
29. Moore R.A., Straube S., Wiffen P.J., et al. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev 2009, (3). CD 007076.
30. Barrett A.M., Lucero M.A., Robinson R.L., et al. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med 2007, 8(Suppl 2):S50-S62.
31. Randinitis E.J., Posvar E.L., Alvey C.W., et al. Pharmacokinetics of pregabalin in subjects with various degrees of renal function. JClin Pharmacol 2003, 43:277-283.
32. Raja S.N., Haythornwaite J.A., Pappagallo M., et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo controlled trial. Neurology 2002, 59:1015-1021.
33. Jensen T.S., Madsen C.S., Finnerup N.B. Pharmacology and treatment of neuropathic pains. Curr Opin Neurol 2009, 22:467-474.
34. Sindrup S.H., Andersen G., Madsen C., et al. Tramadol relieves pain and allodynia in polyneuropathy: a randomized, double-blind, controlled trial. Pain 2003, 83:85-90.
35. Harati Y., Gooch C., Swenson M., et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998, 50:1842-1846.
36. Jones D., Story D.A. Serotonin syndrome and the anaesthetist. Anaesth Intensive Care 2005, 32(2):181-187.
37. Derry S., Moore R. Topical capsaicin (low concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2012, (9). CD010111.
38. Mason L., Moore R.A., Derry S., et al. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 2004, 328:991.
39. Gilron I., Bailey J.M., Dongsheng T., et al. Morphine, gabapentin, or their combination for neuropathic pain. NEngl J Med 2005, 352:1324-1334.
40. Gilron I., Bailey J.M., Tu D., et al. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomized controlled crossover trial. Lancet 2009, 374:1252-1261.
41. Kumar V., Krone K., Mathieu A. Neuraxial and sympathetic blocks in herpes zoster and postherpetic neuralgia: an appraisal of current evidence. Reg Anesth Pain Med 2004, 29:454-461.
42. Pasqualucci A., Pasqualucci V., Galla F., et al. Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta Anaesthesiol Scand 2000, 44:910-918.
43. van Wijck A.J., Opstelten W., Moons K.G., et al. The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial. Lancet 2006, 367:219-224.
44. Ji G., Niu J., Shi Y., et al. The effectiveness of repetitive paravertebral injections with local anesthetics and steroids for the prevention of postherpetic neuralgia in patients with acute herpes zoster. Anesth Analg 2009, 109:1651-1655.
45. Chou R., Loeser J.D., Owens D.K., et al. Interventional therapies, surgery, and interdisciplinary rehabilitation for low back pain: an evidence-based clinical practice guideline from the American Pain Society. Spine 2009, 34:1066-1077.
46. Cruccu G., Aziz T.Z., Garcia-Larrea L., et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol 2007, 14:952-970.
47. Simpson E.L., Duenas A., Holmes M.W., et al. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation. Health Technol Assess 2009, 13:1-154.
48. Xiao L., Mackey S., Xong D., et al. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia. Pain Med 2010, 11:1827-1833.
49. Yuan R.Y., Sheu J.J., Chen W.T., et al. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial. Neurology 2009, 72:1473-1478.
50. Ranoux D., Attal N., Morain F., et al. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol 2008, 64:274-283.
51. Duale C., Sibaud F., Guastella V., et al. Perioperative ketamine does not prevent chronic pain after thoracotomy. Eur J Pain 2009, 13:497-505.
52. Senturk M., Ozcan P.E., Talu G.K., et al. The effects of three different analgesia techniques on long-term postthoracotomy pain. Anesth Analg 2002, 94:11-15.
53. Hayes C., Armstrong-Brown A., Burstal R. Perioperative intravenous ketamine infusion for the prevention of persistent post-amputation pain: a randomized controlled trial. Anaesth Intensive Care 2004, 32:330-338.
54. Lambert A.W., Dashfield A.K., Cosgrove C., et al. Randomized prospective study comparing preoperative epidural and intraoperative perinerual analgesia for the prevention of postoperative stump and phantom limb pain following major amputation. Reg Anesth Pain Med 2001, 26:316-321.
55. Nikoljasen L., Ilkjaer S., Christensen J.H., et al. Randomized trial of epidural bupivacaine and morphine in prevention of stump and phantom pain in lower-limb amputation. Lancet 1997, 350:1353-1357.
56. Schley M., Topfner S., Wiech K., et al. Continuous brachial plexus blockade in combination with NMDA receptor antagonist memantine prevents phantom limb pain in acute traumatic upper limb amputees. Eur J Pain 2007, 11:299-308.
57. Zollinger P.E., Tuinbreijer W.E., Beederveld R.S., et al. Can vitamin C prevent complex regional pain syndrome in patients with wrist fracture? A randomized, controlled, multicenter dose-response study. JBone Joint Surg Am 2007, 89:1424-1431.
58. Oxman M.N., Levin M.L., Shingles Prevention Study Group Vaccination against herpes zoster and postherpetic neuralgia. JInfect Dis 2008, 197(Suppl 2):S228-S236.